# China NMPA Drug Inspection - Guangzhou Xiangxue Pharmaceutical Co., Ltd. - Isatis root granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guangzhou-xiangxue-pharmaceutical-co-ltd/c3e602d0-57fe-4f2c-bb2f-d24f4d31ec70/
Source feed: China

> China NMPA drug inspection for Guangzhou Xiangxue Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Isatis root granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Guangzhou Xiangxue Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Isatis root granules
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/guangzhou-xiangxue-pharmaceutical-co-ltd/e4d54070-4f03-4326-9d48-a55aa84e6408/